Western Europe

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

See Prices or Subscribe
Western Europe

Latest Western Europe Analysis

Industry Trend Analysis - Swiss Biotech Companies Face Funding Challenges - AUG 2014

While capital investments in the Swiss biotech sector have not returned to pre-2007/08 financial downturn levels, the outperformance of the SXI Life Sciences Index is encouraging and highlights investor confidence in the sector. Switzerland's biotech industry is strategically important for the country's prosperity given the sector's high value-add.